[MYGN] YoY Quarter Result on 30-Sep-2019 [#Q3]

Stock
[MYGN] Myriad Genetics, Inc.
Announcement Date
05-Nov-2019
Financial Year
2019
Quarter
30-Sep-2019 [#Q3]
Profit Trend
QoQ- -390.48%
YoY- -2,842.86%
Quarter Report
MYGN's Result
MYGN's Financial Summary
View:
Show?
Quarter Result
30/09/22 30/09/21 30/09/20 30/09/19 30/09/18 30/09/17 30/09/16 CAGR
Revenue 156,400 167,300 145,200 186,300 202,300 190,200 177,500 -2.08%
PBT -44,200 39,800 -43,700 -22,300 800 86,600 4,000 -
Tax -9,100 15,200 -28,500 -1,700 1,600 5,600 5,200 -
NP -35,100 24,600 -15,200 -20,600 -700 81,100 -1,200 75.48%
Tax Rate - -38.19% - - -200.00% -6.47% -130.00% -
Total Cost 191,500 142,700 160,400 206,900 203,000 109,100 178,700 1.15%
Ratio Analysis
30/09/22 30/09/21 30/09/20 30/09/19 30/09/18 30/09/17 30/09/16 CAGR
NP Margin -22.44 14.70 -10.47 -11.06 -0.35 42.64 -0.68 79.04%
Per Share
30/09/22 30/09/21 30/09/20 30/09/19 30/09/18 30/09/17 30/09/16 CAGR
EPS -0.43 0.31 -0.20 -0.28 -0.01 1.18 -0.02 66.71%
EPS Diluted -0.43 0.30 -0.20 -0.28 -0.01 1.15 -0.02 66.71%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.